Weight loss is a critical factor to reduce inflammation

Clinical Nutrition ESPEN

Volumn 28, Issue , 2018, Pages 21-35

  Bianchi, Vittorio Emanuele ^a  

^a Clinical Center Stella Maris   (San Marino)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; ADIPONECTIN; AMINO ACID; C REACTIVE PROTEIN; CARBOHYDRATE; CREATINE; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN F2 ALPHA; SEX HORMONE; TRYPTOPHAN; TUMOR NECROSIS FACTOR; TYROSINE; CYTOKINE;

ADIPOSE TISSUE; AGE; AMINO ACID METABOLISM; BARIATRIC SURGERY; BIBLIOGRAPHIC DATABASE; BODY MASS; BODY WEIGHT LOSS; BODY WEIGHT MAINTENANCE; CHRONIC DISEASE; CLINICAL OUTCOME; CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; DIET; DIET THERAPY; ENDOTHELIUM CELL; ENERGY EXPENDITURE; GASTRIC BANDING; GENE EXPRESSION; GLYCEMIC INDEX; HEALTHY DIET; INFLAMMATION; INSULIN RESISTANCE; LOW CALORIE DIET; LOW CARBOHYDRATE DIET; LOW FAT DIET; MEDITERRANEAN DIET; MITOCHONDRION; MORTALITY RISK; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE COMPLICATION; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROUX-EN-Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; TREATMENT DURATION; VERY LOW CALORIE DIET; BLOOD; COMPLICATION; HUMAN; MORBID OBESITY;

CYTOKINES; DIET, REDUCING; HUMANS; INFLAMMATION; OBESITY, MORBID; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT LOSS;

EID: 85052727388     PISSN: 24054577     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnesp.2018.08.007     Document Type: Review

References (221)

1. Shoelson, S.E., Lee, J., Goldfine, A.B., Inflammation and insulin resistance. J Clin Invest 116 (2006), 1793–1801.
2. Wang, X., Bao, W., Liu, J., Ouyang, Y.Y., Wang, D., Rong, S., et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 36 (2013), 166–175.
3. Gui, T., Shimokado, A., Sun, Y., Akasaka, T., Muragaki, Y., Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediat Inflamm, 2012, 2012, 693083.
4. Ridker, P.M., Buring, J.E., Cook, N.R., Rifai, N., C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003), 391–397.
5. Slattery, M.L., Fitzpatrick, F.A., Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology. Cancer Prev Res (Phila) 2 (2009), 922–930.
6. Schetter, A.J., Heegaard, N.H., Harris, C.C., Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31 (2010), 37–49.
7. Calder, P.C., Albers, R., Antoine, J.M., Blum, S., Bourdet-Sicard, R., Ferns, G.A., et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 101:Suppl. 1 (2009), S1–S45.
8. Makki, K., Froguel, P., Wolowczuk, I., Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm, 2013, 2013, 139239.
9. Pepys, M.B., Hirschfield, G.M., C-reactive protein: a critical update. J Clin Invest 111 (2003), 1805–1812.
10. Timpson, N.J., Lawlor, D.A., Harbord, R.M., Gaunt, T.R., Day, I.N., Palmer, L.J., et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 366 (2005), 1954–1959.
11. Singh, T.P., Morris, D.R., Smith, S., Moxon, J.V., Golledge, J., Systematic review and meta-analysis of the association between C-Reactive protein and major cardiovascular events in patients with peripheral artery disease. Eur J Vasc Endovasc Surg 54 (2017), 220–233.
12. de Boer, R.A., Nayor, M., deFilippi, C.R., Enserro, D., Bhambhani, V., Kizer, J.R., et al. Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction. JAMA Cardiol 3 (2018), 215–224.
13. Spoto, B., Di Betta, E., Mattace-Raso, F., Sijbrands, E., Vilardi, A., Parlongo, R.M., et al. Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity. Nutr Metab Cardiovasc Dis 24 (2014), 1137–1143.
14. Ford, E.S., Giles, W.H., Dietz, W.H., Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002), 356–359.
15. Wolk, R., Bertolet, M., Singh, P., Brooks, M.M., Pratley, R.E., Frye, R.L., et al. Prognostic value of adipokines in predicting cardiovascular outcome: explaining the obesity paradox. Mayo Clin Proc 91 (2016), 858–866.
16. de Luca, C., Olefsky, J.M., Inflammation and insulin resistance. FEBS Lett 582 (2008), 97–105.
17. King, G.L., Park, K., Li, Q., Selective insulin resistance and the development of cardiovascular diseases in diabetes: the 2015 edwin Bierman Award lecture. Diabetes 65 (2016), 1462–1471.
18. Callaghan, B., Feldman, E., The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol 74 (2013), 397–403.
19. Boden, S., Wennberg, M., Van Guelpen, B., Johansson, I., Lindahl, B., Andersson, J., et al. Dietary inflammatory index and risk of first myocardial infarction; a prospective population-based study. Nutr J, 16, 2017, 21.
20. Williamson, R., McNeilly, A., Sutherland, C., Insulin resistance in the brain: an old-age or new-age problem?. Biochem Pharmacol 84 (2012), 737–745.
21. Prasad, S., Sung, B., Aggarwal, B.B., Age-associated chronic diseases require age-old medicine: role of chronic inflammation. Prev Med 54 (2012), S29–S37.
22. Phillips, C.M., Perry, I.J., Does inflammation determine metabolic health status in obese and nonobese adults?. J Clin Endocrinol Metab 98 (2013), E1610–E1619.
23. Rock, C.L., Flatt, S.W., Pakiz, B., Quintana, E.L., Heath, D.D., Rana, B.K., et al. Effects of diet composition on weight loss, metabolic factors and biomarkers in a 1-year weight loss intervention in obese women examined by baseline insulin resistance status. Metabolism 65 (2016), 1605–1613.
24. Meydani, S.N., Das, S.K., Pieper, C.F., Lewis, M.R., Klein, S., Dixit, V.D., et al. Long-term moderate calorie restriction inhibits inflammation without impairing cell-mediated immunity: a randomized controlled trial in non-obese humans. Aging (Albany NY) 8 (2016), 1416–1431.
25. Hu, T., Yao, L., Reynolds, K., Whelton, P.K., Niu, T., Li, S., et al. The effects of a low-carbohydrate diet vs. a low-fat diet on novel cardiovascular risk factors: a randomized controlled trial. Nutrients 7 (2015), 7978–7994.
26. Beavers, K.M., Beavers, D.P., Newman, J.J., Anderson, A.M., Loeser, R.F. Jr., Nicklas, B.J., et al. Effects of total and regional fat loss on plasma CRP and IL-6 in overweight and obese, older adults with knee osteoarthritis. Osteoarthritis Cartilage 23 (2015), 249–256.
27. Fisher, G., Hyatt, T.C., Hunter, G.R., Oster, R.A., Desmond, R.A., Gower, B.A., Effect of diet with and without exercise training on markers of inflammation and fat distribution in overweight women. Obesity (Silver Spring) 19 (2011), 1131–1136.
28. Salas-Salvado, J., Garcia-Arellano, A., Estruch, R., Marquez-Sandoval, F., Corella, D., Fiol, M., et al. Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. Eur J Clin Nutr 62 (2008), 651–659.
29. Nicklas, J.M., Sacks, F.M., Smith, S.R., LeBoff, M.S., Rood, J.C., Bray, G.A., et al. Effect of dietary composition of weight loss diets on high-sensitivity c-reactive protein: the Randomized POUNDS LOST trial. Obesity (Silver Spring) 21 (2013), 681–689.
30. Stendell-Hollis, N.R., Thompson, P.A., West, J.L., Wertheim, B.C., Thomson, C.A., A comparison of Mediterranean-style and MyPyramid diets on weight loss and inflammatory biomarkers in postpartum breastfeeding women. J Womens Health (Larchmt) 22 (2013), 48–57.
31. Heggen, E., Klemsdal, T.O., Haugen, F., Holme, I., Tonstad, S., Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations. Metab Syndr Relat Disord 10 (2012), 437–442.
32. Gogebakan, O., Kohl, A., Osterhoff, M.A., van Baak, M.A., Jebb, S.A., Papadaki, A., et al. Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial. Circulation 124 (2011), 2829–2838.
33. Imayama, I., Ulrich, C.M., Alfano, C.M., Wang, C., Xiao, L., Wener, M.H., et al. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res 72 (2012), 2314–2326.
34. Golan, R., Tirosh, A., Schwarzfuchs, D., Harman-Boehm, I., Thiery, J., Fiedler, G.M., et al. Dietary intervention induces flow of changes within biomarkers of lipids, inflammation, liver enzymes, and glycemic control. Nutrition 28 (2012), 131–137.
35. van Bussel, B.C., Henry, R.M., Ferreira, I., van Greevenbroek, M.M., van der Kallen, C.J., Twisk, J.W., et al. A healthy diet is associated with less endothelial dysfunction and less low-grade inflammation over a 7-year period in adults at risk of cardiovascular disease. J Nutr 145 (2015), 532–540.
36. Juanola-Falgarona, M., Salas-Salvado, J., Ibarrola-Jurado, N., Rabassa-Soler, A., Diaz-Lopez, A., Guasch-Ferre, M., et al. Effect of the glycemic index of the diet on weight loss, modulation of satiety, inflammation, and other metabolic risk factors: a randomized controlled trial. Am J Clin Nutr 100 (2014), 27–35.
37. Merra, G., Gratteri, S., De Lorenzo, A., Barrucco, S., Perrone, M.A., Avolio, E., et al. Effects of very-low-calorie diet on body composition, metabolic state, and genes expression: a randomized double-blind placebo-controlled trial. Eur Rev Med Pharmacol Sci 21 (2017), 329–345.
38. Dyer, J., Davison, G., Marcora, S.M., Mauger, A.R., Effect of a mediterranean type diet on inflammatory and cartilage degradation biomarkers in patients with osteoarthritis. J Nutr Health Aging 21 (2017), 562–566.
39. Moller, K., Ostermann, A.I., Rund, K., Thoms, S., Blume, C., Stahl, F., et al. Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-alpha, interleukin-6, and oxylipins in obese subjects. Prostaglandins Leukot Essent Fatty Acids 106 (2016), 39–49.
40. Kirwan, J.P., Malin, S.K., Scelsi, A.R., Kullman, E.L., Navaneethan, S.D., Pagadala, M.R., et al. A whole-grain diet reduces cardiovascular risk factors in overweight and obese adults: a randomized controlled trial. J Nutr 146 (2016), 2244–2251.
41. Pedersen, L.R., Olsen, R.H., Anholm, C., Walzem, R.L., Fenger, M., Eugen-Olsen, J., et al. Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: a randomized trial. Atherosclerosis 246 (2016), 221–228.
42. Magkos, F., Fraterrigo, G., Yoshino, J., Luecking, C., Kirbach, K., Kelly, S.C., et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab 23 (2016), 591–601.
43. Song, X., Kestin, M., Schwarz, Y., Yang, P., Hu, X., Lampe, J.W., et al. A low-fat high-carbohydrate diet reduces plasma total adiponectin concentrations compared to a moderate-fat diet with no impact on biomarkers of systemic inflammation in a randomized controlled feeding study. Eur J Nutr 55 (2016), 237–246.
44. Ho, T.P., Zhao, X., Courville, A.B., Linderman, J.D., Smith, S., Sebring, N., et al. Effects of a 12-month moderate weight loss intervention on insulin sensitivity and inflammation status in nondiabetic overweight and obese subjects. Horm Metab Res 47 (2015), 289–296.
45. Ryan, A.S., Ge, S., Blumenthal, J.B., Serra, M.C., Prior, S.J., Goldberg, A.P., Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women. J Am Geriatr Soc 62 (2014), 607–614.
46. Khoo, J., Dhamodaran, S., Chen, D.D., Yap, S.Y., Chen, R.Y., Tian, R.H., Exercise-induced weight loss is more effective than dieting for improving adipokine profile, insulin resistance, and inflammation in obese men. Int J Sport Nutr Exerc Metab 25 (2015), 566–575.
47. Miller, G.D., Isom, S., Morgan, T.M., Vitolins, M.Z., Blackwell, C., Brosnihan, K.B., et al. Effects of a community-based weight loss intervention on adipose tissue circulating factors. Diabetes Metab Syndr 8 (2014), 205–211.
48. Lopez-Legarrea, P., de la Iglesia, R., Abete, I., Navas-Carretero, S., Martinez, J.A., Zulet, M.A., The protein type within a hypocaloric diet affects obesity-related inflammation: the RESMENA project. Nutrition 30 (2014), 424–429.
49. Strasser, B., Berger, K., Fuchs, D., Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults. Eur J Nutr 54 (2015), 101–107.
50. Trussardi Fayh, A.P., Lopes, A.L., Fernandes, P.R., Reischak-Oliveira, A., Friedman, R., Impact of weight loss with or without exercise on abdominal fat and insulin resistance in obese individuals: a randomised clinical trial. Br J Nutr 110 (2013), 486–492.
51. Blesso, C.N., Andersen, C.J., Barona, J., Volk, B., Volek, J.S., Fernandez, M.L., Effects of carbohydrate restriction and dietary cholesterol provided by eggs on clinical risk factors in metabolic syndrome. J Clin Lipidol 7 (2013), 463–471.
52. Tajik, N., Keshavarz, S.A., Masoudkabir, F., Djalali, M., Sadrzadeh-Yeganeh, H.H., Eshraghian, M.R., et al. Effect of diet-induced weight loss on inflammatory cytokines in obese women. J Endocrinol Invest 36 (2013), 211–215.
53. Neuhouser, M.L., Schwarz, Y., Wang, C., Breymeyer, K., Coronado, G., Wang, C.Y., et al. A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr 142 (2012), 369–374.
54. Bougoulia, M., Triantos, A., Koliakos, G., Plasma interleukin-6 levels, glutathione peroxidase and isoprostane in obese women before and after weight loss. Association with cardiovascular risk factors. Hormones (Athens) 5 (2006), 192–199.
55. Kasim-Karakas, S.E., Tsodikov, A., Singh, U., Jialal, I., Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake. Am J Clin Nutr 83 (2006), 774–779.
56. Giannopoulou, I., Fernhall, B., Carhart, R., Weinstock, R.S., Baynard, T., Figueroa, A., et al. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 54 (2005), 866–875.
57. Jellema, A., Plat, J., Mensink, R.P., Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest 34 (2004), 766–773.
58. Sharman, M.J., Volek, J.S., Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond) 107 (2004), 365–369.
59. Arvidsson, E., Viguerie, N., Andersson, I., Verdich, C., Langin, D., Arner, P., Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 53 (2004), 1966–1971.
60. Seshadri, P., Iqbal, N., Stern, L., Williams, M., Chicano, K.L., Daily, D.A., et al. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med 117 (2004), 398–405.
61. Xydakis, A.M., Case, C.C., Jones, P.H., Hoogeveen, R.C., Liu, M.Y., Smith, E.O., et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 89 (2004), 2697–2703.
62. You, T., Berman, D.M., Ryan, A.S., Nicklas, B.J., Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. J Clin Endocrinol Metab 89 (2004), 1739–1746.
63. Bruun, J.M., Verdich, C., Toubro, S., Astrup, A., Richelsen, B., Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol 148 (2003), 535–542.
64. Bruun, J.M., Pedersen, S.B., Kristensen, K., Richelsen, B., Opposite regulation of interleukin-8 and tumor necrosis factor-alpha by weight loss. Obes Res 10 (2002), 499–506.
65. Bastard, J.P., Jardel, C., Bruckert, E., Blondy, P., Capeau, J., Laville, M., et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85 (2000), 3338–3342.
66. Tchernof, A., Nolan, A., Sites, C.K., Ades, P.A., Poehlman, E.T., Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105 (2002), 564–569.
67. Heilbronn, L.K., Noakes, M., Clifton, P.M., Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 21 (2001), 968–970.
68. Johnstone, A.M., Lobley, G.E., Horgan, G.W., Bremner, D.M., Fyfe, C.L., Morrice, P.C., et al. Effects of a high-protein, low-carbohydrate v. high-protein, moderate-carbohydrate weight-loss diet on antioxidant status, endothelial markers and plasma indices of the cardiometabolic profile. Br J Nutr 106 (2011), 282–291.
69. Hermsdorff, H.H., Zulet, M.A., Abete, I., Martinez, J.A., Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects. Endocrine 36 (2009), 445–451.
70. Christiansen, T., Paulsen, S.K., Bruun, J.M., Ploug, T., Pedersen, S.B., Richelsen, B., Diet-induced weight loss and exercise alone and in combination enhance the expression of adiponectin receptors in adipose tissue and skeletal muscle, but only diet-induced weight loss enhanced circulating adiponectin. J Clin Endocrinol Metab 95 (2010), 911–919.
71. Davis, N.J., Crandall, J.P., Gajavelli, S., Berman, J.W., Tomuta, N., Wylie-Rosett, J., et al. Differential effects of low-carbohydrate and low-fat diets on inflammation and endothelial function in diabetes. J Diabet Complicat 25 (2011), 371–376.
72. Bladbjerg, E.M., Larsen, T.M., Due, A., Stender, S., Astrup, A., Jespersen, J., Effects on markers of inflammation and endothelial cell function of three ad libitum diets differing in type and amount of fat and carbohydrate: a 6-month randomised study in obese individuals. Br J Nutr 106 (2011), 123–129.
73. Sola, E., Jover, A., Lopez-Ruiz, A., Jarabo, M., Vaya, A., Morillas, C., et al. Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss. Obes Surg 19 (2009), 571–576.
74. Campion, J., Milagro, F.I., Goyenechea, E., Martinez, J.A., TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver Spring) 17 (2009), 1293–1297.
75. de Mello, V.D., Kolehmainen, M., Schwab, U., Mager, U., Laaksonen, D.E., Pulkkinen, L., et al. Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome. Metabolism 57 (2008), 192–199.
76. Madsen, E.L., Rissanen, A., Bruun, J.M., Skogstrand, K., Tonstad, S., Hougaard, D.M., et al. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol 158 (2008), 179–187.
77. Lima, M.M., Pareja, J.C., Alegre, S.M., Geloneze, S.R., Kahn, S.E., Astiarraga, B.D., et al. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers. Obesity (Silver Spring) 21 (2013), E182–E189.
78. Dalmas, E., Rouault, C., Abdennour, M., Rovere, C., Rizkalla, S., Bar-Hen, A., et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr 94 (2011), 450–458.
79. Gogebakan, O., Osterhoff, M.A., Schuler, R., Pivovarova, O., Kruse, M., Seltmann, A.C., et al. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial. Diabetologia 58 (2015), 1759–1768.
80. Ramel, A., Martinez, J.A., Kiely, M., Bandarra, N.M., Thorsdottir, I., Effects of weight loss and seafood consumption on inflammation parameters in young, overweight and obese European men and women during 8 weeks of energy restriction. Eur J Clin Nutr 64 (2010), 987–993.
81. Marques-Rocha, J.L., Milagro, F.I., Mansego, M.L., Zulet, M.A., Bressan, J., Martinez, J.A., Expression of inflammation-related miRNAs in white blood cells from subjects with metabolic syndrome after 8 wk of following a Mediterranean diet-based weight loss program. Nutrition 32 (2016), 48–55.
82. Hermsdorff, H.H., Zulet, M.A., Abete, I., Martinez, J.A., A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects. Eur J Nutr 50 (2011), 61–69.
83. Pendyala, S., Neff, L.M., Suarez-Farinas, M., Holt, P.R., Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. Am J Clin Nutr 93 (2011), 234–242.
84. Clement, K., Viguerie, N., Poitou, C., Carette, C., Pelloux, V., Curat, C.A., et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18 (2004), 1657–1669.
85. Bielohuby, M., Menhofer, D., Kirchner, H., Stoehr, B.J., Muller, T.D., Stock, P., et al. Induction of ketosis in rats fed low-carbohydrate, high-fat diets depends on the relative abundance of dietary fat and protein. Am J Physiol Endocrinol Metab 300 (2011), E65–E76.
86. Kord-Varkaneh, H., Fatahi, S., Alizadeh, S., Ghaedi, E., Shab-Bidar, S., Association of serum leptin with all-cause and disease specific mortality: a meta-analysis of prospective observational studies. Horm Metab Res 50 (2018), 509–520.
87. Lips, M.A., van Klinken, J.B., Pijl, H., Janssen, I., Willems van Dijk, K., Koning, F., et al. Weight loss induced by very low calorie diet is associated with a more beneficial systemic inflammatory profile than by Roux-en-Y gastric bypass. Metabolism 65 (2016), 1614–1620.
88. Santos, J., Salgado, P., Santos, C., Mendes, P., Saavedra, J., Baldaque, P., et al. Effect of bariatric surgery on weight loss, inflammation, iron metabolism, and lipid profile. Scand J Surg 103 (2014), 21–25.
89. Illan-Gomez, F., Gonzalvez-Ortega, M., Orea-Soler, I., Alcaraz-Tafalla, M.S., Aragon-Alonso, A., Pascual-Diaz, M., et al. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg 22 (2012), 950–955.
90. Bueter, M., Dubb, S.S., Gill, A., Joannou, L., Ahmed, A., Frankel, A.H., et al. Renal cytokines improve early after bariatric surgery. Br J Surg 97 (2010), 1838–1844.
91. Moschen, A.R., Molnar, C., Geiger, S., Graziadei, I., Ebenbichler, C.F., Weiss, H., et al. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut 59 (2010), 1259–1264.
92. Cancello, R., Henegar, C., Viguerie, N., Taleb, S., Poitou, C., Rouault, C., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54 (2005), 2277–2286.
93. Hanusch-Enserer, U., Cauza, E., Spak, M., Dunky, A., Rosen, H.R., Wolf, H., et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord 27 (2003), 355–361.
94. Vink, R.G., Roumans, N.J., Fazelzadeh, P., Tareen, S.H., Boekschoten, M.V., van Baak, M.A., et al. Adipose tissue gene expression is differentially regulated with different rates of weight loss in overweight and obese humans. Int J Obes (Lond) 41 (2017), 309–316.
95. Johansson, L.E., Danielsson, A.P., Parikh, H., Klintenberg, M., Norstrom, F., Groop, L., et al. Differential gene expression in adipose tissue from obese human subjects during weight loss and weight maintenance. Am J Clin Nutr 96 (2012), 196–207.
96. Siklova-Vitkova, M., Klimcakova, E., Polak, J., Kovacova, Z., Tencerova, M., Rossmeislova, L., et al. Adipose tissue secretion and expression of adipocyte-produced and stromavascular fraction-produced adipokines vary during multiple phases of weight-reducing dietary intervention in obese women. J Clin Endocrinol Metab 97 (2012), E1176–E1181.
97. Tchoukalova, Y.D., Votruba, S.B., Tchkonia, T., Giorgadze, N., Kirkland, J.L., Jensen, M.D., Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A 107 (2010), 18226–18231.
98. Zemel, M.B., Mechanisms of dairy modulation of adiposity. J Nutr 133 (2003), 252S–256S.
99. Kershaw, E.E., Flier, J.S., Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004), 2548–2556.
100. Sahin-Efe, A., Katsikeris, F., Mantzoros, C.S., Advances in adipokines. Metabolism 61 (2012), 1659–1665.
101. Liu, Y.M., Lacorte, J.M., Viguerie, N., Poitou, C., Pelloux, V., Guy-Grand, B., et al. Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding. J Clin Endocrinol Metab 88 (2003), 5881–5886.
102. Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annu Rev Immunol 29 (2011), 415–445.
103. Bastard, J.P., Maachi, M., Lagathu, C., Kim, M.J., Caron, M., Vidal, H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17 (2006), 4–12.
104. Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116 (2006), 1494–1505.
105. Hui, X., Zhang, M., Gu, P., Li, K., Gao, Y., Wu, D., et al. Adipocyte SIRT1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue. EMBO Rep 18 (2017), 645–657.
106. Greenberg, A.S., Obin, M.S., Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83 (2006), 461S–465S.
107. Wellen, K.E., Hotamisligil, G.S., Inflammation, stress, and diabetes. J Clin Invest 115 (2005), 1111–1119.
108. Ahima, R.S., Flier, J.S., Leptin. Annu Rev Physiol 62 (2000), 413–437.
109. McConway, M.G., Johnson, D., Kelly, A., Griffin, D., Smith, J., Wallace, A.M., Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adult humans. Ann Clin Biochem 37:Pt 5 (2000), 717–723.
110. Friedman, J.M., The function of leptin in nutrition, weight, and physiology. Nutr Rev 60 (2002), S1–S14 Discussion S68-84, 5-7.
111. Myers, M.G. Jr., Leibel, R.L., Seeley, R.J., Schwartz, M.W., Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 21 (2010), 643–651.
112. Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993), 87–91.
113. Koistinen, H.A., Bastard, J.P., Dusserre, E., Ebeling, P., Zegari, N., Andreelli, F., et al. Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects. Eur J Clin Invest 30 (2000), 302–310.
114. Tanaka, T., Narazaki, M., Kishimoto, T., IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol, 6, 2014, a016295.
115. Acosta, J.R., Douagi, I., Andersson, D.P., Backdahl, J., Ryden, M., Arner, P., et al. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes. Diabetologia 59 (2016), 560–570.
116. Carey, A.L., Bruce, C.R., Sacchetti, M., Anderson, M.J., Olsen, D.B., Saltin, B., et al. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia 47 (2004), 1029–1037.
117. Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y., Libby, P., Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) 110 (2006), 267–278.
118. Zoico, E., Garbin, U., Olioso, D., Mazzali, G., Fratta Pasini, A.M., Di Francesco, V., et al. The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: role of the NF-kappaB pathway. Int J Mol Med 24 (2009), 847–851.
119. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003), 762–769.
120. Yamauchi, T., Kadowaki, T., Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond) 32:Suppl. 7 (2008), S13–S18.
121. Gan, L., Yan, J., Liu, Z., Feng, M., Sun, C., Adiponectin prevents reduction of lipid-induced mitochondrial biogenesis via AMPK/ACC2 pathway in chicken adipocyte. J Cell Biochem 116 (2015), 1090–1100.
122. Jeon, M.J., Leem, J., Ko, M.S., Jang, J.E., Park, H.S., Kim, H.S., et al. Mitochondrial dysfunction and activation of iNOS are responsible for the palmitate-induced decrease in adiponectin synthesis in 3T3L1 adipocytes. Exp Mol Med 44 (2012), 562–570.
123. Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464 (2010), 1313–1319.
124. Koh, E.H., Park, J.Y., Park, H.S., Jeon, M.J., Ryu, J.W., Kim, M., et al. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 56 (2007), 2973–2981.
125. Ohashi, K., Yuasa, D., Shibata, R., Murohara, T., Ouchi, N., Adiponectin as a target in obesity-related inflammatory state. Endocr Metab Immune Disord Drug Targets 15 (2015), 145–150.
126. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K., Tobe, K., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116 (2006), 1784–1792.
127. Lihn, A.S., Bruun, J.M., He, G., Pedersen, S.B., Jensen, P.F., Richelsen, B., Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219 (2004), 9–15.
128. Yin, X., Lanza, I.R., Swain, J.M., Sarr, M.G., Nair, K.S., Jensen, M.D., Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. J Clin Endocrinol Metab 99 (2014), E209–E216.
129. Kopecky, J., Rossmeisl, M., Flachs, P., Bardova, K., Brauner, P., Mitochondrial uncoupling and lipid metabolism in adipocytes. Biochem Soc Trans 29 (2001), 791–797.
130. Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M.A., Chui, P.C., Leszyk, J., et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 114 (2004), 1281–1289.
131. Pietilainen, K.H., Naukkarinen, J., Rissanen, A., Saharinen, J., Ellonen, P., Keranen, H., et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med, 5, 2008, e51.
132. Dahlman, I., Forsgren, M., Sjogren, A., Nordstrom, E.A., Kaaman, M., Naslund, E., et al. Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha. Diabetes 55 (2006), 1792–1799.
133. Villarroya, J., Giralt, M., Villarroya, F., Mitochondrial DNA: an up-and-coming actor in white adipose tissue pathophysiology. Obesity (Silver Spring) 17 (2009), 1814–1820.
134. Choo, H.J., Kim, J.H., Kwon, O.B., Lee, C.S., Mun, J.Y., Han, S.S., et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49 (2006), 784–791.
135. Park, H.S., Park, J.Y., Yu, R., Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69 (2005), 29–35.
136. You, T., Yang, R., Lyles, M.F., Gong, D., Nicklas, B.J., Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab 288 (2005), E741–E747.
137. Tilg, H., Moschen, A.R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6 (2006), 772–783.
138. Chudek, J., Wiecek, A., Adipose tissue, inflammation and endothelial dysfunction. Pharmacol Rep 58 (2006), 81–88.
139. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004), 1752–1761.
140. Tormos, K.V., Anso, E., Hamanaka, R.B., Eisenbart, J., Joseph, J., Kalyanaraman, B., et al. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab 14 (2011), 537–544.
141. Lin, C.Y., Duan, H., Mazzone, T., Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E. J Lipid Res 40 (1999), 1618–1627.
142. Lin, Y., Berg, A.H., Iyengar, P., Lam, T.K., Giacca, A., Combs, T.P., et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 280 (2005), 4617–4626.
143. Bales, C.W., Kraus, W.E., Caloric restriction: implications for human cardiometabolic health. J Cardiopulm Rehabil Prev 33 (2013), 201–208.
144. Lafontan, M., Langin, D., Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 48 (2009), 275–297.
145. Grams, J., Garvey, W.T., Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep 4 (2015), 287–302.
146. Sacks, F.M., Bray, G.A., Carey, V.J., Smith, S.R., Ryan, D.H., Anton, S.D., et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360 (2009), 859–873.
147. de la Iglesia, R., Loria-Kohen, V., Zulet, M.A., Martinez, J.A., Reglero, G., Ramirez de Molina, A., Dietary strategies implicated in the prevention and treatment of metabolic syndrome. Int J Mol Sci, 17, 2016.
148. Wing, R.R., Lang, W., Wadden, T.A., Safford, M., Knowler, W.C., Bertoni, A.G., et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 34 (2011), 1481–1486.
149. Rossmeislova, L., Malisova, L., Kracmerova, J., Stich, V., Adaptation of human adipose tissue to hypocaloric diet. Int J Obes (Lond) 37 (2013), 640–650.
150. Joris, P.J., Plat, J., Kusters, Y.H., Houben, A.J., Stehouwer, C.D., Schalkwijk, C.G., et al. Diet-induced weight loss improves not only cardiometabolic risk markers but also markers of vascular function: a randomized controlled trial in abdominally obese men. Am J Clin Nutr 105 (2017), 23–31.
151. Summer, S.S., Brehm, B.J., Benoit, S.C., D'Alessio, D.A., Adiponectin changes in relation to the macronutrient composition of a weight-loss diet. Obesity (Silver Spring) 19 (2011), 2198–2204.
152. Christiansen, T., Richelsen, B., Bruun, J.M., Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 29 (2005), 146–150.
153. Bouche, C., Rizkalla, S.W., Luo, J., Vidal, H., Veronese, A., Pacher, N., et al. Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care 25 (2002), 822–828.
154. Qi, L., van Dam, R.M., Liu, S., Franz, M., Mantzoros, C., Hu, F.B., Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care 29 (2006), 207–211.
155. de Mello, V.D., Kolehmainen, M., Pulkkinen, L., Schwab, U., Mager, U., Laaksonen, D.E., et al. Downregulation of genes involved in NFkappaB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study. Diabetologia 51 (2008), 2060–2067.
156. Gredilla, R., Barja, G., Minireview: the role of oxidative stress in relation to caloric restriction and longevity. Endocrinology 146 (2005), 3713–3717.
157. Steckhan, N., Hohmann, C.D., Kessler, C., Dobos, G., Michalsen, A., Cramer, H., Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: a systematic review and meta-analysis. Nutrition 32 (2016), 338–348.
158. Stern, L., Iqbal, N., Seshadri, P., Chicano, K.L., Daily, D.A., McGrory, J., et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 140 (2004), 778–785.
159. Ellsworth, D.L., Mamula, K.A., Blackburn, H.L., McDyer, F.A., Jellema, G.L., van Laar, R., et al. Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification. Obesity (Silver Spring) 23 (2015), 1312–1319.
160. Forsythe, L.K., Wallace, J.M., Livingstone, M.B., Obesity and inflammation: the effects of weight loss. Nutr Res Rev 21 (2008), 117–133.
161. Selvin, E., Paynter, N.P., Erlinger, T.P., The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167 (2007), 31–39.
162. Capel, F., Klimcakova, E., Viguerie, N., Roussel, B., Vitkova, M., Kovacikova, M., et al. Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization. Diabetes 58 (2009), 1558–1567.
163. Labonte, M.E., Cyr, A., Abdullah, M.M., Lepine, M.C., Vohl, M.C., Jones, P., et al. Dairy product consumption has no impact on biomarkers of inflammation among men and women with low-grade systemic inflammation. J Nutr 144 (2014), 1760–1767.
164. Katzmarzyk, P.T., Leon, A.S., Wilmore, J.H., Skinner, J.S., Rao, D.C., Rankinen, T., et al. Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. Med Sci Sports Exerc 35 (2003), 1703–1709.
165. Lindstrom, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J.G., Hemio, K., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368 (2006), 1673–1679.
166. Christiansen, T., Paulsen, S.K., Bruun, J.M., Pedersen, S.B., Richelsen, B., Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. Am J Physiol Endocrinol Metab 298 (2010), E824–E831.
167. Muoio, D.M., Neufer, P.D., Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab 15 (2012), 595–605.
168. Santos, R.F., Sztalryd, C., Reaven, G., Effect of anatomical site on insulin action and insulin receptor phosphorylation in isolated rat adipocytes. Int J Obes 15 (1991), 755–762.
169. Portillo, M.P., Villaro, J.M., Torres, M.I., Macarulla, M.T., In vivo lipolysis in adipose tissue from two anatomical locations measured by microdialysis. Life Sci 67 (2000), 437–445.
170. Marin, T.L., Gongol, B., Zhang, F., Martin, M., Johnson, D.A., Xiao, H., et al. AMPK promotes mitochondrial biogenesis and function by phosphorylating the epigenetic factors DNMT1, RBBP7, and HAT1. Sci Signal, 10, 2017.
171. De Pauw, A., Tejerina, S., Raes, M., Keijer, J., Arnould, T., Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am J Pathol 175 (2009), 927–939.
172. Stallknecht, B., Vinten, J., Ploug, T., Galbo, H., Increased activities of mitochondrial enzymes in white adipose tissue in trained rats. Am J Physiol 261 (1991), E410–E414.
173. Steinberg, G.R., Jorgensen, S.B., The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Rev Med Chem 7 (2007), 519–526.
174. Sponarova, J., Mustard, K.J., Horakova, O., Flachs, P., Rossmeisl, M., Brauner, P., et al. Involvement of AMP-activated protein kinase in fat depot-specific metabolic changes during starvation. FEBS Lett 579 (2005), 6105–6110.
175. Ruderman, N.B., Park, H., Kaushik, V.K., Dean, D., Constant, S., Prentki, M., et al. AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta Physiol Scand 178 (2003), 435–442.
176. List, E.O., Berryman, D.E., Wright-Piekarski, J., Jara, A., Funk, K., Kopchick, J.J., The effects of weight cycling on lifespan in male C57BL/6J mice. Int J Obes (Lond) 37 (2013), 1088–1094.
177. Benton, C.R., Wright, D.C., Bonen, A., PGC-1alpha-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions. Appl Physiol Nutr Metab 33 (2008), 843–862.
178. Scarpulla, R.C., Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 1813 (2011), 1269–1278.
179. Chaube, B., Malvi, P., Singh, S.V., Mohammad, N., Viollet, B., Bhat, M.K., AMPK maintains energy homeostasis and survival in cancer cells via regulating p38/PGC-1alpha-mediated mitochondrial biogenesis. Cell Death Discov, 1, 2015, 15063.
180. Canto, C., Auwerx, J., Calorie restriction: is AMPK a key sensor and effector?. Physiology (Bethesda) 26 (2011), 214–224.
181. Cohen, H.Y., Miller, C., Bitterman, K.J., Wall, N.R., Hekking, B., Kessler, B., et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305 (2004), 390–392.
182. Gerhart-Hines, Z., Rodgers, J.T., Bare, O., Lerin, C., Kim, S.H., Mostoslavsky, R., et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 26 (2007), 1913–1923.
183. Price, N.L., Gomes, A.P., Ling, A.J., Duarte, F.V., Martin-Montalvo, A., North, B.J., et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15 (2012), 675–690.
184. Klemsdal, T.O., Holme, I., Nerland, H., Pedersen, T.R., Tonstad, S., Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome. Nutr Metab Cardiovasc Dis 20 (2010), 195–201.
185. Simpson, S.J., Le Couteur, D.G., Raubenheimer, D., Putting the balance back in diet. Cell 161 (2015), 18–23.
186. Bach-Faig, A., Berry, E.M., Lairon, D., Reguant, J., Trichopoulou, A., Dernini, S., et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr 14 (2011), 2274–2284.
187. Middleton, G., Keegan, R., Smith, M.F., Alkhatib, A., Klonizakis, M., Brief report: implementing a mediterranean diet intervention into a RCT: lessons learned from a non-mediterranean based Country. J Nutr Health Aging 19 (2015), 1019–1022.
188. Solon-Biet, S.M., Walters, K.A., Simanainen, U.K., McMahon, A.C., Ruohonen, K., Ballard, J.W., et al. Macronutrient balance, reproductive function, and lifespan in aging mice. Proc Natl Acad Sci USA 112 (2015), 3481–3486.
189. Solon-Biet, S.M., Mitchell, S.J., Coogan, S.C., Cogger, V.C., Gokarn, R., McMahon, A.C., et al. Dietary protein to carbohydrate ratio and caloric restriction: comparing metabolic outcomes in mice. Cell Rep 11 (2015), 1529–1534.
190. Newgard, C.B., Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 15 (2012), 606–614.
191. Rizkalla, S.W., Prifti, E., Cotillard, A., Pelloux, V., Rouault, C., Allouche, R., et al. Differential effects of macronutrient content in 2 energy-restricted diets on cardiovascular risk factors and adipose tissue cell size in moderately obese individuals: a randomized controlled trial. Am J Clin Nutr 95 (2012), 49–63.
192. Dong, J.Y., Zhang, Y.H., Wang, P., Qin, L.Q., Meta-analysis of dietary glycemic load and glycemic index in relation to risk of coronary heart disease. Am J Cardiol 109 (2012), 1608–1613.
193. Fan, J., Song, Y., Wang, Y., Hui, R., Zhang, W., Dietary glycemic index, glycemic load, and risk of coronary heart disease, stroke, and stroke mortality: a systematic review with meta-analysis. PLoS One, 7, 2012, e52182.
194. Costantino, S., Paneni, F., Cosentino, F., Hyperglycemia: a bad signature on the vascular system. Cardiovasc Diagn Ther 5 (2015), 403–406.
195. Tay, J., Thompson, C.H., Luscombe-Marsh, N.D., Wycherley, T.P., Noakes, M., Buckley, J.D., et al. Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: a 2-year randomized clinical trial. Diabetes Obes Metab 4 (2017), 858–871.
196. Jenkins, D.J., Kendall, C.W., Augustin, L.S., Franceschi, S., Hamidi, M., Marchie, A., et al. Glycemic index: overview of implications in health and disease. Am J Clin Nutr 76 (2002), 266S–273S.
197. Barclay, A.W., Petocz, P., McMillan-Price, J., Flood, V.M., Prvan, T., Mitchell, P., et al. Glycemic index, glycemic load, and chronic disease risk–a meta-analysis of observational studies. Am J Clin Nutr 87 (2008), 627–637.
198. Kristo, A.S., Matthan, N.R., Lichtenstein, A.H., Effect of diets differing in glycemic index and glycemic load on cardiovascular risk factors: review of randomized controlled-feeding trials. Nutrients 5 (2013), 1071–1080.
199. Hartman, T.J., Albert, P.S., Zhang, Z., Bagshaw, D., Kris-Etherton, P.M., Ulbrecht, J., et al. Consumption of a legume-enriched, low-glycemic index diet is associated with biomarkers of insulin resistance and inflammation among men at risk for colorectal cancer. J Nutr 140 (2010), 60–67.
200. Raatz, S.K., Torkelson, C.J., Redmon, J.B., Reck, K.P., Kwong, C.A., Swanson, J.E., et al. Reduced glycemic index and glycemic load diets do not increase the effects of energy restriction on weight loss and insulin sensitivity in obese men and women. J Nutr 135 (2005), 2387–2391.
201. Stimson, R.H., Johnstone, A.M., Homer, N.Z., Wake, D.J., Morton, N.M., Andrew, R., et al. Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men. J Clin Endocrinol Metab 92 (2007), 4480–4484.
202. Zheng, Q., Zhao, K., Han, X., Huff, A.F., Cui, Q., Babcock, S.A., et al. Inhibition of AMPK accentuates prolonged caloric restriction-induced change in cardiac contractile function through disruption of compensatory autophagy. Biochim Biophys Acta 1852 (2015), 332–342.
203. Choi, M.S., Kim, Y.J., Kwon, E.Y., Ryoo, J.Y., Kim, S.R., Jung, U.J., High-fat diet decreases energy expenditure and expression of genes controlling lipid metabolism, mitochondrial function and skeletal system development in the adipose tissue, along with increased expression of extracellular matrix remodelling- and inflammation-related genes. Br J Nutr 113 (2015), 867–877.
204. Bullen, J.W. Jr., Bluher, S., Kelesidis, T., Mantzoros, C.S., Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 292 (2007), E1079–E1086.
205. Ramos-Ramirez, P., Malmhall, C., Johansson, K., Lotvall, J., Bossios, A., Weight gain alters adiponectin receptor 1 expression on adipose tissue-resident Helios+ regulatory T cells. Scand J Immunol 83 (2016), 244–254.
206. Barnea, M., Shamay, A., Stark, A.H., Madar, Z., A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity (Silver Spring) 14 (2006), 2145–2153.
207. Caughey, G.E., Mantzioris, E., Gibson, R.A., Cleland, L.G., James, M.J., The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63 (1996), 116–122.
208. Itariu, B.K., Zeyda, M., Hochbrugger, E.E., Neuhofer, A., Prager, G., Schindler, K., et al. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am J Clin Nutr 96 (2012), 1137–1149.
209. Telle-Hansen, V.H., Christensen, J.J., Ulven, S.M., Holven, K.B., Does dietary fat affect inflammatory markers in overweight and obese individuals?-a review of randomized controlled trials from 2010 to 2016. Genes Nutr, 12, 2017, 26.
210. Calder, P.C., N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38 (2003), 343–352.
211. Serhan, C.N., Arita, M., Hong, S., Gotlinger, K., Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39 (2004), 1125–1132.
212. Lin, N., Shi, J.J., Li, Y.M., Zhang, X.Y., Chen, Y., Calder, P.C., et al. What is the impact of n-3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis, 15, 2016, 133.
213. Klein-Platat, C., Drai, J., Oujaa, M., Schlienger, J.L., Simon, C., Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 82 (2005), 1178–1184.
214. Jia, K., Levine, B., Autophagy is required for dietary restriction-mediated life span extension in C. elegans. Autophagy 3 (2007), 597–599.
215. Ajala, O., English, P., Pinkney, J., Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97 (2013), 505–516.
216. Fontana, L., Klein, S., Aging, adiposity, and calorie restriction. JAMA 297 (2007), 986–994.
217. Paquot, N., Castillo, M.J., Lefebvre, P.J., Scheen, A.J., No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. J Clin Endocrinol Metab 85 (2000), 1316–1319.
218. Ofei, F., Hurel, S., Newkirk, J., Sopwith, M., Taylor, R., Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45 (1996), 881–885.
219. Richard, C., Couture, P., Ooi, E.M., Tremblay, A.J., Desroches, S., Charest, A., et al. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome. Arterioscler Thromb Vasc Biol. 34 (2014), 433–438.
220. Jonasson, L., Guldbrand, H., Lundberg, A.K., Nystrom, F.H., Advice to follow a low-carbohydrate diet has a favourable impact on low-grade inflammation in type 2 diabetes compared with advice to follow a low-fat diet. Ann Med 46 (2014), 182–187.
221. Clifton, P.M., Keogh, J.B., Foster, P.R., Noakes, M., Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets. Int J Obes (Lond) 29 (2005), 1445–1451.